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Biotransformation of 3,-acetoxy-19-hydroxycholest-5-ene (19-HCA, 6 g) by Moraxella sp. was studied.
Estrone (712 mg) was the major metabolite formed. Minor metabolites identified were 5a-androst-1-en-19-ol-
3,17-dione (33 mg), androst-4-en-19-ol-3,17-dione (58 mg), androst-4-en-9a,19-diol-3,17-dione (12 mg), and
androstan-19-ol-3,17-dione (1 mg). Acidic metabolites were not formed. Time course experiments on the
fermentation of 19-HCA indicated that androst-4-en-19-ol-3,17-dione was the major metabolite formed during
the early stages of incubation. However, with continuing fermentation its level dropped, with a concomitant
increase in estrone. Fermentation of 19-HCA in the presence of specific inhibitors or performing the
fermentation for a shorter period (48 h) did not result in the formation of acidic metabolites. Resting-cell
experiments carried out with 19-HCA (200 mg) in the presence of a,a'-bipyridyl led to the isolation of three
additional metabolites, viz., cholestan-19-ol-3-one (2 mg), cholest-4-en-19-ol-3-one (10 mg), and cholest-5-en-
3jS,19-diol (12 mg). Similar results were also obtained when n-propanol was used instead of a,o'-bipyridyl.
Resting cells grown on 19-HCA readily converted both 5G-androst-1-en-19-ol-3,17-dione and androst-4-en-19-
ol-3,17-dione into estrone. Partially purified 1,2-dehydrogenase from steroid-induced Moraxella cells trans-
formed androst-4-en-19-ol-3,17-dione into estrone and formaldehyde in the presence of phenazine methosul-
fate, an artificial electron acceptor. These results suggest that the degradation of the hydrocarbon side chain
of 19-HCA does not proceed via C22 phenolic acid intermediates and complete removal of the C17 side chain
takes place prior to the aromatization of the A ring in estrone. The mode of degradation of the sterol side chain
appears to be through the fission of the C17-C20 bond. On the basis of these observations, a new pathway for
the formation of estrone from 19-HCA in Moraxella sp. has been proposed.
Cholesterol and phytosterols have long been considered
potential starting materials for the microbial production of
steroid hormones. Studies pertaining to microbial degradation
of the hydrocarbon side chain of various sterols have been
comprehensively documented (1, 2, 6, 16, 18, 19, 22-24, 26). It
was demonstrated that prior to side-chain cleavage in sterols,
the organism initially oxidizes the A ring to a 4-en-3-one
structure. At this stage, the organism carries out the oxidation
of the terminal methyl group of the side chain, followed by
,B-oxidation. Thus, the hydrocarbon side chain is degraded via
C26, C24, and C22 acids to Cl9 androstane derivatives. These
studies have clearly established that the acidic intermediates
play an important role in the microbial conversion of sterols to
17-keto steroids (1, 6, 16, 18, 19, 22-24, 26). Studies have also
shown that microbes are able to metabolize the bulkier side
chain of 1-sitosterol in a manner analogous to cholesterol
degradation (18, 19).
Sterol-degrading microorganisms are generally known to
possess both side chain- and steroid nucleus-degrading activi-
ties (16). The nucleus-degrading activity can be prevented
either by using specific inhibitor or by chemically modifying the
substrate (16). Modified sterols such as cholest-4-en-19-ol-3-
one and 3p-acetoxy-19-hydroxycholest 5-ene (19-HCA) have
been shown to be converted into estrone microbiologically
(22-24). These studies have clearly demonstrated that the
degradation of the C17 side chain proceeds via C22 phenolic
acid intermediates (22-24). The three-carbon side chain of C22
phenolic acid is cleaved to estrone and propionic acid, suggest-
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ing that the complete removal of the C17 side chain takes place
only after the aromatization of the A ring (22-24).
During our attempts to develop a microbial process to
selectively eliminate the C17 side chain of cholesterol or its
derivatives, a soil microorganism belonging to the genus
Moraxella was isolated by an enrichment culture technique
using a model compound isooctylcyclopentane as the sole
source of carbon (2, 11). The organism also accepted choles-
terol and 19-HCA (metabolite I) as the sole source of carbon.
Earlier, it was shown that this organism converts 19-HCA (I)
into estrone (II) (2). However, attempts were not made to
establish the degradative sequence in the conversion of I into
II.
The present study was initiated to gain information regard-
ing the aromatization of the A ring with the steroid nucleus
intact and cleavage of the C17 side chain. We report here the
isolation and identification of neutral metabolites from 19-
HCA and propose a new pathway for the microbial conversion
of 19-HCA (I) into estrone (II) without the involvement of C22
phenolic acid intermediates. The neutral metabolites III, IV,
V, VI, VII, and IX have never been shown as metabolites
derived from 19-HCA (I), and among them III appears to be
hitherto unknown.
MATERUILS AND METHODS
Materials. 19-HCA (I) was synthesized by following the
procedure of Kalvoda et al. (10). Cholesterol, androst-4-en-19-
ol-3,17-dione (IV) and ot,a'-bipyridyl (ox,ot'-D) were procured
from Sigma Chemical Co. (St. Louis, Mo.). All reference
steroids were 100% pure as judged by thin-layer chromatog-
raphy (TLC) and high-performance liquid chromatography
(HPLC).
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Methods. Infrared (IR) spectra, UV spectra, nuclear mag-
netic resonance (NMR) spectra, and mass spectra (MS) were
obtained as described previously (17). HPLC analysis was
carried out on a Water Associates ALC/GPC 244 series
instrument. The analysis was performed on a ,u-Porasil normal-
phase column with chloroform-methanol (95:5, vol/vol) as the
solvent system. Eluents were monitored with a UV detector at
254 nm. TLC analyses were performed on silica gel G plates
(0.5 mm thick) developed with ethyl acetate-hexane (1:1,
vol/vol, system I; 1:3, vol/vol, system II) as solvent systems. The
compounds were visualized by spraying with 50% H2SO4
followed by heating at 100°C for 5 to 10 min.
Culture conditions. The organism used in this study was
propagated on mineral salts medium (20) containing 0.05%
cholesterol and 2% agar (pH 7.2). It was maintained regularly
in liquid mineral salts medium containing 0.05% cholesterol as
the carbon source. Whenever starter culture was required, an
aliquot (5 ml) from the maintenance culture was transferred to
100 ml of a sterilized liquid mineral salts medium (pH 7.2)
containing 0.05% cholesterol and incubated on a rotary shaker
(220 rpm) at 29 to 30°C for 3 days. These studies were carried
out with 3-day-grown culture as the inoculum. Although the
organism accepts 19-HCA (I) as the sole source of carbon, the
growth rate is slow. Hence, to enhance the growth rate, 0.2%
glucose was added to the medium when the fermentation of
19-HCA was carried out.
Metabolism of 19-HCA (I). Flasks containing 100 ml of
sterile mineral salts medium (20), 0.2% glucose, and 0.05%
19-HCA (I) were inoculated from a 3-day-old culture (5.0 ml)
and incubated at 29 to 30°C on a rotary shaker (220 rpm) for
7 days. At the end of the incubation period, the contents were
pooled, acidified to pH 3 to 4, and then extracted with an equal
volume of dichloromethane (extracted three times). The
pooled extracts were concentrated, washed first with 10%
sodium bicarbonate and then with distilled water, and dried
over anhydrous sodium sulfate. After evaporation, the meth-
ylene chloride extract yielded neutral steroid metabolites. The
bicarbonate layer after acidification and extraction with meth-
ylene chloride did not contain any acidic metabolites and
hence was not processed further. Fermentation of 19-HCA (I)
was also carried out for a shorter duration (48 h), and the
culture media were processed as already described.
Metabolism of 19-HCA (I) in the presence of inhibitors. The
organism was grown in mineral salts medium containing 0.2%
glucose and 0.05% 19-HCA for 36 h. After this growth period,
a,a'-D (0.6 mM) or n-propanol (2%) was added and the
incubation continued for an additional 48 h. At the end of the
incubation period, the medium was acidified to pH 3 to 4,
extracted with dichloromethane, washed with water, and then
separated into acidic and neutral fractions. These fractions
were subjected to TLC and HPLC analyses. Control experi-
ments were run without the inhibitors.
Metabolism of 19-HCA by resting cells (i) without inhibitor
and (ii) with inhibitor (viz., a,a'-D and n-propanol). Cells
were grown in mineral salts medium containing 0.2% glucose
and 0.05% 19-HCA for 48 h. The cells were harvested by
centrifugation (3,000 x g for 20 min) and washed well with
phosphate buffer (0.03 M, pH 7.2) aseptically. The washed cells
(-1 g) were then suspended in sterile phosphate buffer (50 ml,
0.03 M, pH 7.2). To this cell suspension, (i) 50 mg of 19-HCA
was added for the experiment without inhibitors and (ii) for the
experiment with inhibitors, the substrate addition was followed
by the addition of the respective inhibitors, a,ct'-D (0.6 mM)
and n-propanol (2%). It was then incubated at 30°C for a total
of 48 h. Fixed aliquots at definite intervals (12, 24, and 48 h)
were withdrawn, extracted with dichloromethane, and sepa-
rated into acidic and neutral fractions as already described.
The acid fractions did not contain any steroid metabolites and
hence were not processed further. The neutral fractions were
subjected to TLC and HPLC analyses.
Large-scale resting-cell experiment. A batch of 20 flasks
containing glucose (0.2%) and 19-HCA (0.05%) was inocu-
lated with Moraxella cells as already described. At the end of
the incubation period (48 h), the cells (4 g) were harvested,
washed, and suspended in phosphate buffer, as described
earlier. To this cell suspension (200 ml), 19-HCA (I; 200 mg)
and a,a'-D (0.6 mM) were added and incubation at 30°C
continued for 48 h. From the culture medium, acidic and
neutral metabolites were separated as described earlier. The
acidic fraction did not contain any steroid metabolites and
hence was not processed further.
Metabolism of androst-4-en-19-ol-3,17-dione (lV) by resting
cells. Cells grown (48 h) on 19-HCA were washed with
phosphate buffer (0.03 M, pH 7.2) aseptically and then sus-
pended (1 g) in the same buffer (25 ml). To this cell suspen-
sion, IV (25 mg) was added and incubated for 48 h. Transfor-
mation products formed were monitored by taking fixed
aliquots (5 ml) at different time intervals for extraction and
analysis by HPLC. This experiment was repeated with Sa-
androst-1-en-19-ol-3,17-dione (III).
Preparation of cell extract. Steroid-induced cells grown for
48 h were washed twice with ice-cold phosphate buffer (0.03 M,
pH 7.2) and suspended in Tris buffer (0.03 M, pH 7.5)
containing 10% glycerol (2 ml/g [wet weight] of cells). The cell
suspension was sonicated in a Branson B-30 sonifier with
cooling for 10 30-s intervals at maximum output. The sonicate
was centrifuged at 105,000 x g for 2 h, and the supernatant
(650 mg) was applied to a DEAE-cellulose column (3 by 12
cm) previously equilibrated with 0.03 M Tris-HCl buffer (pH
7.5) containing 10% glycerol (buffer A). After the column was
washed with buffer A (500 ml), it was successively eluted with
buffer A containing 0.1 M KCl (250 ml) and 0.2 M KCl (250
ml). The 0.2 M KCl eluate contained most of the 1,2-dehydro-
genase activity. This fraction, upon concentration by ultrafil-
tration (P-10 membrane) and dialyzing (10 to 12 h) against
buffer A, yielded nearly sevenfold purified enzyme (60 mg).
Enzyme assay. 1,2-Dehydrogenase activity was determined
by measuring the rate of 2,6-dichlorophenol-indophenol
(DCIP) reduction at 600 nm in a mixture consisting of phos-
phate buffer (0.03 M, pH 7.5), enzyme (1 mg), phenazine
methosulfate (0.4 ,umol), DCIP (0.45 ,umol), and progesterone
(1.2 ,umol in 6 ,ul of acetone) in a total volume of 3 ml. The
reaction was initiated by the addition of substrate (progester-
one). The reduction of DCIP was measured using an extinction
coefficient of 21 x 103 M-t cm-' (25). The enzyme readily
converts progesterone to 1,2-dehydroprogesterone. The pro-
tein determinations were made by the method of Lowry et al.
(12).
Conversion of androst-4-en-19-ol-3,17-dione (IV) to estrone
(II) by 1,2-dehydrogenase. Partially purified enzyme (50 mg)
was incubated with IV (16.5 pumol) and phenazine methosul-
fate (20 pumol) in phosphate buffer (75 ml, 0.03 M, pH 7.5) at
30°C for 1 h. The assay was terminated by the addition of 2 N
HCl, and the suspension was centrifuged. One half of the
supernatant was extracted twice with methylene chloride, and
the enzymatic product formed was isolated and characterized.
To the other half, 2,4-dinitrophenylhydrazine reagent was
added and the derivative formed was isolated, purified, and
characterized.
Manometric studies. Manometric studies were performed
with a Gilson 5/6 Oxygraph at 30°C. The 48-h-grown cells
adapted to 19-HCA were harvested, washed, and suspended in
VOL. 60, 1994
1514 MADYASTHA AND SHANKAR
Tris-HCl buffer (0.03 M, pH 7.2) to give a final A660 of 1.1.
From this, 0.5 ml was used for the oxygen uptake studies.
6-Methylheptan-2-one (25 ,ug in 5 ,ul of acetone) was used as
the substrate. The reaction mixture consisted of 1.5 ml of Tris
buffer (0.03 M, pH 7.2) and 0.5 ml of the cell suspension. After
the endogenous oxygen consumption was complete, the reac-
tion was initiated with the addition of 6-methylheptan-2-one.
RESULTS
Metabolism of 19-HCA (I). A batch of 120 flasks containing
19-HCA (0.05%) was inoculated with Moraxella cells, and at
the end of the incubation period, the contents were pooled and
processed as described above. The crude neutral fraction (4.8
g) was subjected to column chromatography on silica gel (140
g), and the unmetabolized 19-HCA (I; 3.4 g) was eluted with
5% ethyl acetate in hexane. Elution of the column with 7%
ethyl acetate in hexane yielded the major metabolite (II; 712
mg, Rf 0.67, system I) whose IR, NMR, and MS corresponded
well with an authentic sample of estrone (II). Subsequently,
the column was eluted with methanol to collect all the polar
metabolites. This fraction (fraction I; 370 mg) upon TLC
analysis (system I) showed the presence of seven metabolites
(Rf 0.52, 0.4, 0.38, 0.29, 0.26, 0.18, and 0.1) four of which are
present at very low levels. Fraction I (370 mg) was further
subjected to column chromatography on silica gel (7.0 g), and
the 15% ethyl acetate-in-hexane eluate (fraction II; 5 mg)
contained one major (Rf 0.38, system I) and a few minor
metabolites. Subsequently, the column was eluted with 20%
ethyl acetate in hexane, and the early eluate contained a polar
metabolite (33 mg, Rf 0.26, system I) in the pure form
(compound A). From the latter fractions, another polar me-
tabolite (58 mg, Rf 0.18, system I) was isolated (compound B).
Finally, the column was eluted with 100% ethyl acetate from
which the most polar metabolite (12 mg, Rf 0.1, system I) was
obtained (compound C). Fraction II was again subjected to
column chromatography over silica gel (1 g), and the com-
pound with Rf 0.38 (system I) was eluted with 15% ethyl
acetate in benzene (1 mg; compound D). All the metabolites
isolated (A, B, C, and D) were subjected to various spectral
analyses. The other minor neutral metabolites could not be
isolated in the pure form and hence could not be characterized.
Compound A. Recrystallization of this compound (from
CH2Cl2-hexane) gave white crystals (33 mg), melting point
(mp) 182 to 183°C; [aID24 + 150 (c 0.6 in methanol [MeOH]);
UV (MeOH)/nm 228; IR (Nujol)/cm1-l 3,440 (-OH), 1,730
(- C==O), and 1,680 (t,4-unsaturated ketone); NMR (270
MHz, CDC13) BH: 0.92 (3H, s, 18-CH3), 3.83 (1H, d,J = 11.25
Hz, 19-CH2), 4.1 (1H, d, J = 11.25 Hz, 19-CH2), 6.13 (1H, d,
Jcis = 10.13 Hz, 2-H); 7.06 (1H, d, Jci, = 10.13 Hz, 1-H), NMR(90 MHz, CDCl3) 58: 14.18, 21.34, 21.86, 27.45, 30.58, 32.0,
35.78, 36.04, 41.90, 43.98, 44.50, 48.14, 50.36, 52.05, 61.42,
131.03 (1-C), 153.66 (2-C), 201.16 (3-C), and 221.06 (17-C);
MS: m/z 302 (M+, 42%), 284 (M+-H2O, 9%), 272 (base peak,
M+-CH2O, 100%) and 108 (M+-C12H1802, 81%); high reso-
lution mass spectra (HRMS): found M+ 302.1884 C19H2603
requires M+ 302.1882. On the basis of spectral analyses,
compound A was identified as androst-1-en-19-ol-3,17-dione
(III). The ring junction between A and B was established as
trans by X-ray analysis (X-ray data will be published else-
where). Thus the compound was identified as 5ot-androst-1-en-
19-ol-3,17-dione (Fig. 1, III). Compound III appears to be
hitherto unknown.
Compound B. Recrystallization of this compound (from
MeOH) gave white crystals (58 mg) with an mp of 168 to
1690C. This was identified as androst-4-en-19-ol-3,17-dione
21
12 l 2
I
'I
FIG. 1. Proposed pathway for the metabolism
hydroxycholest-5-ene (I) by Moraxella sp.
of 313-acetoxy-19-
(Fig. 1, IV) by comparison (IR, NMR, MS, and HPLC) with
the authentic sample. The melting point of IV is the same as
that reported for androst-4-en-19-ol-3,17-dione (3).
Compound C. Recrystallization of this compound (from
MeOH) gave white crystals (12 mg) with an mp of 252 to
253°C. UV (MeOH)/nm 242; IR (Nujol)/cm-1 3,502, 3,376
(- OH), 1,728 (- C-O), 1,647 (ao,-unsaturated ketone), and
1,614 (C==C); NMR (270 MHz, CDCl3) 8H: 0.92 (3H, s,
18-CH3), 3.92 (1H, d,J = 11.25 Hz, 19-CH2), 4.14 (1H, d,J =
11.25 Hz, 19-CH2) and 6.09 (1H, s, 4-H); MS: mlz 318 (M+,
10%), 300 (M+-H2O, 55%) 288 (M+-CH2O, 32%), 282 (M+-
2H20, 15%), 270 (base peak, M+-[CH2O + H20], 100%);
HRMS: found M+ 318.182 C19H2604 requires M+ 318.1831).
The 'H NMR spectrum of this compound is similar to that of
androst-4-en-19-ol-3,17-dione (IV). However, both IR spectral
and MS analyses indicated the presence of one more hydroxyl
than in compound IV. The proton NMR pattern suggests that
the second hydroxyl is tertiary in nature and the possible
positions are 8,B, 9a, and 14ot. The absence of deshielding of
18-CH3 protons rules out the possibility of a hydroxyl group at
position 14ot. So, the logical conclusion is that the hydroxyl
group may be at either the 83 or 9a position. X-ray analysis of
compound C conclusively established that the position of the
tertiary hydroxyl is at 9cx (5). Hence, metabolite C was identi-
fied as androst-4-en-9ot,19-diol-3,17-dione (Fig. 1, V).
Compound D. Recrystallization of this compound gave a
white residue (1 mg), NMR (90 MHz, CDCl3) 8H: 0.86 (3H, s,
18-CH3), 3.84 to 4.28 (2H, m, 19-CH2); MS: M+ 304 (60%)
and m/z 286 (M+-H2O, 10%) 273 (M+-CH2OH, 15%);
HRMS: found M+ 304.2039 C19H2803 requires M+ 304.2039.
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FIG. 2. Time course experiment: metabolism of 3,B-acetoxy-19-
hydroxycholest-5-ene (I) by Moraxella sp. 0, 19-hydroxyandrost-4-en-
3,17-dione; *, estrone.
The 'H NMR spectrum of this compound showed the absence
of an olefinic proton (no signal between 5 and 7.5 8). The MS
analysis suggested that the molecular weight is two units higher
than that of compound IV. On the basis of these observations,
compound D was tentatively identified as androstan-19-ol-
3,17-dione (Fig. 1, VI). Because of the paucity of the material,
further analysis could not be carried out to confirm the
structure assigned.
The time course plot (Fig. 2) on the fermentation of
19-HCA (I) carried out for a period of 7 days indicated that
during the early stages of incubation (2 days), very little
19-HCA was metabolized (ca. 10%) and among the metabo-
lites formed only androst-4-en-19-ol-3,17-dione (IV) was
present in detectable amounts. However, prolonging the incu-
bation period to 3 days resulted in the accumulation of IV (ca.
80% of the total metabolites formed, as judged by HPLC
analyses) and low levels of estrone (II). When the fermentation
was continued beyond 3 days and up to 7 days, the level of IV
dropped gradually (Fig. 2), with a concomitant increase in II.
In fact, at the end of 7 days, estrone (II) was the major
metabolite formed and it was noticed that nearly 40% of the
added 19-HCA (I) was utilized during this period (determined
by the amount of unreacted 19-HCA recovered at the end of 7
days). The presence of metabolites III and V could be seen
only after 3 days in small quantities (together constituting
nearly 10% of the total metabolites formed; data not shown).
Metabolism of 19-HCA (I) in the presence of inhibitors.
Fermentation was carried out in the presence of inhibitors as
described above. TLC analysis of the neutral fractions ob-
tained when o,a'-D and n-propanol were used as inhibitors
revealed the presence of not only estrone (II) and androst-4-
en-19-ol-3,17-dione (IV) but also three additional metabolites,
E (Rf 0.33, system II), F (Rf 0.19, system II), and G (Rf 0.07,
system II), which were not noticed when the fermentation was
carried out without the inhibitors. Acidic metabolites were not
formed even in the presence of inhibitors. The HPLC profile of
the neutral fraction indicated that a,a'-D inhibited the forma-
tion of androst-4-en-9ot,19-diol-3,17-dione (V), whereas its
presence was seen at low levels when n-propanol was used as
the inhibitor. It is interesting that higher levels of metabolites
E, F, and G were formed when resting cells were incubated
with 19-HCA in the presence of x,a'-D. The HPLC analysis
showed the accumulation of one compound (later isolated and
identified as compound F). Hence, a large-scale resting-cell
experiment was carried out to isolate and characterize metab-
olites E, F, and G.
A large-scale resting-cell experiment carried out in the
presence of a,ot'-D as described above yielded 145 mg of crude
neutral fraction, which was subjected to chromatography on a
column of silica gel (4 g). The unmetabolized 19-HCA (109
mg) and estrone (II) were eluted from the column with 5 and
15% ethyl acetate in hexane, respectively. Further elution of
the column with 20, 25, and 30% ethyl acetate in hexane
yielded compounds E (2 mg, Rf 0.33, system II), F (10 mg, Rf
0.19, system II), and G (12 mg, Rf 0.07, system II), respectively,
in the pure form. Compounds E, F, and G were subjected to
various spectral analyses.
Compound E. Recrystallization of this compound (from
MeOH) gave a white residue (2 mg), IR (CHCl3)/cm- 1,707
(- C==O); NMR (90 MHz, CDCl3) 8H: 0.62 (3H, s, 18-CH3),
0.74 to 0.96 (9H, m, 21, 26, and 27-CH3), 3.8 to 4.2 (2H, m,
19-CH2), and the ring methylene and methine protons appear
as a multiplet in the region 1-2.5 8; MS: m/z 402 (M+, 20%)
and 371 (M+-CH2OH, 10%); HRMS: found M+ 402.3517
C27H4602 requires M+ 402.3498. On the basis of these spectral
analyses, compound E was identified as cholestan-19-ol-3-one
(Fig. 1, VII).
Compound F. Recrystallization of this compound (from
MeOH) gave a white residue (10 mg), UV (MeOH)/nm 256;
IR (CHCl3)/cm 1 3,388 (- OH), 1,662 (ao,,-unsaturated ke-
tone); NMR (90 MHz, CDCl3) 8H: 0.69 (3H, s, 18-CH3), 0.76
to 1.0 (9H, m, 21, 26, and 27-CH3), 3.97 (2H, ABq,JAB = 11.25
Hz, AVAB = 19.2 Hz, 19-CH2), 5.94 (1H, s, 4-H), and the ring
methylene and methine protons appear as a multiplet in the
region 1-2.5 8; MS: m/z 400 (M+, 20%) and 370 (M+-CH2O,
70%); HRMS: found M+ 400.3417 C27H4402 requires M+
400.3341. On the basis of these spectral data, compound F was
assigned the structure cholest-4-en-19-ol-3-one (Fig. 1, VIII).
Compound G. Recrystallization of this compound (from
MeOH) gave a white residue (12 mg), IR (CHCl3)/cm '3,580,
3,406 (- OH); NMR (90 MHz, CDCl3) SH: 0.73 (3H, s,
18-CH3), 0.76 to 1.0 (9H, m, 21, 26, and 27-CH3), 3.4 to 3.9
(3H, m, 3-H and 19-CH2), 5.73 (1H, broad singlet, 6-H), and
the ring methylene and methine protons appear as a multiplet
in the region 1-2.5 8; MS: mlz 402 (M+, 3%), 384 (M+-H2O,
30%), 372 (M+-CH2O, 20%), and 354 (base peak, (M+-
[H20+CH2O], 100%); HRMS: found M+ 402.3366 C27H4602
requires M+ 402.3498. On the basis of these spectral data,
compound G was identified as cholest-5-en-3,,19-diol (Fig. 1,
IX). The spectral data corresponded well with those of cholest-
5-en-31-19-diol prepared chemically by alkaline hydrolysis of
19-HCA (I).
Time course of transformation of 19-HCA (I) by resting cells
in the presence and absence of inhibitors. The HPLC profiles
of the neutral metabolites formed at the end of 12, 24, and 48
h, when 19-HCA (I) was incubated with resting cells in the
presence and absence of inhibitors, are shown in Fig. 3.
Incubation carried out in the absence of inhibitors clearly
indicated (Fig. 3a) that during the early stages (12 h), cholest-
4-en-19-ol-3-one (VIII) was the major metabolite formed,
whereas the levels of estrone (II) and androst-4-en-19-ol-3,17-
dione (IV) were comparatively lower. However, by prolonging
the incubation period to 24 and 48 h, the levels of VIII
dropped significantly with a concomitant increase in II and IV.
During this period, a considerable amount of androst-4-en-
9a,19-diol-3,17-dione (V) was formed (Fig. 3a). When the
experiment was carried out in the presence of a,a'-D, the level
of VIII increased steadily with time, and at the end of 48 h, it
was present at significantly high levels. During this period,
androst-4-en-9a,19-diol-3,17-dione (V) was not formed at all
VOL. 60, 1994
1516 MADYASTHA AND SHANKAR
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FIG. 3. Transformation of 3J3-acetoxy-19-hydroxycholest-5-ene (I)
by resting cells in control (a) and at,ox'-D (b) reactions. (i), endogenous
material from the cell (Rt = 6.5); (ii), estrone (R, = 7.0); (viii),
19-hydroxycholest-4-en-3-one (R, = 7.75); (iv) 19-hydroxyandrost-4-
en-3,17-dione (Rt = 9.0); (v) 9a,19-dihydroxyandrost-4-en-3,17-dione
(Rt = 14.5).
and II and IV were present at extremely low levels (Fig. 3b).
Similar results were also noticed when n-propanol was used
instead of o,a'-D, although cholest-4-en-19-ol-3-one (VIII)
was present at comparatively lower levels. Besides, n-propanol
did not completely inhibit the formation of V, and levels of II
and IV were higher than those in the experiment with c,ct'-D.
Hence, a large-scale experiment was carried out with a,oa'-D to
isolate VIII.
Transformation of androst-4-en-19-ol-3,17-dione (IV) with
resting cells. Transformation products formed at different time
intervals (12, 24, and 48 h) were analyzed by HPLC (Fig. 4a).
It was noticed that the level of androst-4-en-19-ol-3,17-dione
(IV) dropped gradually, with a concomitant increase in the
level of estrone, and at the end of 24 h, nearly 80% of IV was
converted into estrone (II). During this period, androst-4-en-
9ox,19-diol-3,19-dione (V) was formed at low levels (10 to 15%
of the total product formed). A similar experiment carried out
using androst-1-en-19-ol-3,17-dione (III) as the substrate also
indicated its conversion to estrone (II) (Fig. 4b). However, the
rate of conversion of III to II was considerably slower than the
rate of conversion of IV to II. In fact, after 24 h, nearly 40% of
III was converted into estrone (II).
Metabolism of androst-4-en-19-ol-3,17-dione (IV) in vitro.
Partially purified 1,2-dehydrogenase was incubated with an-
drost-4-en-19-ol-3,17-dione (IV) in the presence of phenazine
methosulfate, as described above. One half of the assay
mixture when extracted with methylene chloride yielded an
enzymatic product (Rf 0.67, system I), purified by preparative
thin-layer chromatography (system I) and identified as estrone
(II) on the basis of NMR, MS, and HPLC analyses. To the
other half of the assay mixture, 2,4-dinitrophenylhydrazine
reagent was added and the hydrazone derivative formed was
purified and identified as that of formaldehyde by comparison
of the mass spectrum with that of the chemically prepared
sample.
Manometric studies. Manometric studies using 6-methyl-
heptan-2-one were carried out as described above. The amount
of 02 consumed at 30°C is 19.8 nmol/min/mg (dry wt).
DISCUSSION
The data reported herein suggest that Moraxella sp. trans-
forms 19-HCA (I) into estrone (II) by following a pathway
(Fig. 1) different from that established earlier (22-24). The
degradation of the hydrocarbon side chain of 19-HCA (I) does
not appear to proceed via C22 acid intermediates. Cursory
examination of all the metabolites formed from 19-HCA (I)
and time course experiments provide information regarding
the sequence of reactions taking place during the formation of
estrone (II) and suggest that aromatization of the A ring in II
takes place only after the cleavage of the C17 side chain. The
time course study on the fermentation of 19-HCA (I) (Fig. 2)
and resting-cell experiments carried out with androst-4-en-19-
ol-3,17-dione (IV) (Fig. 4a) clearly indicate the precursor-
product relationship between metabolites IV and II. 5ot-
Androst-1-en-19-ol-3,17-dione (III) and androst-4-en-9cx,19-
diol-3,17-dione (V) were formed only in small quantities, and
at no time did they constitute more than 10% of the total
metabolites formed. The cell extract prepared from steroid-
induced cells contained higher levels of steroid 1,2-dehydroge-
nase than 4,5-dehydrogenase. The specific activities of the
1,2-dehydrogenase and 4,5-dehydrogenase were 3.143 and
0.667 nmol/min/mg, respectively. So, it appears that the major
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FIG. 4. Time course experiments. (a) Transformation of 19-hy-
droxyandrost-4-en-3,17-dione (IV) by resting cells. 0, 19-hydroxyan-
drost-4-en-3,17-dione (IV); 0, estrone (II). (b) Transformation of
19-hydroxyandrost-1-en-3,17-dione (III) by resting cells. Ol, 19-hy-
droxyandrost-1-en-3,17-dione (III); 0, estrone (II).
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metabolite estrone (II) is formed mostly from androst-4-en-
19-ol-3,17-dione (IV) through the action of 1,2-dehydroge-
nase. The introduction of a 1,2-double bond in a steroid
molecule has been reported for several microbial species (4, 8,
9, 13-15) but not previously for Moraxella sp. We have clearly
demonstrated by using partially purified enzyme that introduc-
tion of a 1,2-double bond in androst-4-en-19-ol-3,17-dione
(IV) facilitates a spontaneous nonenzymatic retroaldol-type
reaction to yield estrone (II) and formaldehyde. One would
also expect a similar rearrangement to take place by introduc-
ing a 4,5-double bond in metabolite III. In accordance with
that, we have shown that the resting cells transform III into
estrone (II).
Our studies carried out with Moraxella sp. appear to differ
from those reported earlier (24), where it was demonstrated
that the microbial degradation of cholest-4-en-19-ol-3-one
(VIII) into estrone (II) proceeds via C22 phenolic acid inter-
mediates. In that case, the three-carbon side chain of the C22
phenolic acid is cleaved to estrone (II) and propionic acid,
suggesting that the complete removal of the C17 side chain
takes place only after the aromatization of the A ring (24).
Similar observations were also made by Arima et al. (1), noting
that a species of Nocardia produces pregna-1,4-dien-3-one-20-
carboxylic acid during the fermentation of cholesterol in the
presence of ot,ot'-D. Further, it was established that the degra-
dation of the side chain involves carbon-carbon bond fission at
C24-C25, C22-C23, and C17-C20, resulting in the formation of
17-keto steroid (18). The mode of degradation of the hydro-
carbon side chain of cholesterol in the microbial system differs
from that of the mammalian system, which involves the
cleavage of the C20-C22 and C17-C20 bonds (21). Our results
appear to be different from either of these two modes of
fission. We were not able to demonstrate the formation of
acidic metabolites from 19-HCA (I) when the transformation
was carried out in the presence of specific inhibitors or for a
shorter duration, suggesting that acidic intermediates are not
involved in the degradative sequence. So, it is quite possible
that Moraxella sp. carries out the direct cleavage of the side
chain of cholest-4-en-19-ol-3-one (VIII) between C17 and C20
to yield androst-4-en-19-ol-3,17-dione (IV) and 6-methylhep-
tan-2-one. Our efforts to isolate 6-methylheptan-2-one from
the incubation mixture consisting of 19-HCA (I) and resting
cells were not successful. Interestingly, we have noticed that
cells adapted to 19-HCA readily metabolize 6-methylheptan-
2-one and the manometric studies with 6-methylheptan-2-one
confirmed this observation. Earlier, Horvath and Kramli re-
ported the isolation of 6-methylheptan-2-one after incubating
cholesterol with Azotobacter sp., suggesting the fission of the
side chain is between C17 and C20 (7).
The hitherto unknown 5a-androst-1-en-19-ol-3,17-dione
(III) could have been formed from cholestan-19-ol-3-one
(VII). Earlier, workers from our laboratory showed that side-
chain cleavage takes place independently even when the A ring
is blocked (2). Hence, side-chain cleavage can take place even
in the absence of a 3-keto-4-en system. It is reasonable to
assume that the fission of the side chain in VII takes place
between C17 and C20, in a manner analogous to the side-chain
cleavage of cholest-4-en-19-ol-3-one (VIII), yielding andro-
stan-19-ol-3,17-dione (VI). 1,2-Dehydrogenation of metabolite
VI results in the formation of neutral metabolite III (Fig. 1). In
fact, earlier it was demonstrated that S5t-androstan-3,17-dione
was 1,2-dehydrogenated by Corynebacterium simplex, indicat-
ing that the dehydrogenase does not have any rigid require-
ment for a 4-en-3-one structure (27).
Many investigators have used inhibitors to enable detection
of intermediary metabolites (18, 19). The addition of chelating
agents such as a,ot'-D to cholesterol-decomposing microorgan-
isms not only inhibits the 9oa-hydroxylation reaction, but also
induces the accumulation of acidic intermediates. In this study,
it was observed that incubation carried out in the presence of
a,xa'-D or n-propanol did not result in the formation of acidic
metabolites. However, a,a'-D completely inhibited 9a-hy-
droxylation when resting cells were incubated with 19-HCA (I)
(Fig. 3). Besides, metabolite (VIII) was formed in appreciable
amounts (Fig. 3). Similarly, the accumulation of cholest-4-en-
3-one in the medium was observed during the microbial
degradation of cholesterol in the presence of ot,a'-D or
n-propanol (18).
It appears that the pathway (Fig. 1) involved in the biotrans-
formation of 19-HCA (I) into estrone (II) is initiated by the
hydrolysis of the 3,-acetate moiety followed by the oxidation
of the 3p-hydroxyl group, with concomitant isomerization of
the 5,6-double bond to a 4-en-3-one structure prior to side-
chain cleavage. Resting-cell experiments carried out in the
presence of specific inhibitors clearly demonstrated the forma-
tion of cholest-4-en-19-ol-3-one (VIII). Once metabolite VIII
is formed, the organism cleaves the side chain between C17 and
C20 to yield metabolite IV and methylheptanone. The conver-
sion of IV into II is initiated by the enzyme 1,2-dehydrogenase.
Thus, we have established that the degradation of the hydro-
carbon side chain of 19-HCA (I) does not appear to proceed
via C22 acid intermediates, but instead neutral metabolites play
a key role in the conversion of 19-HCA (I) into estrone (II).
Besides, complete removal of the C17 side chain takes place
prior to the aromatization of the A ring in estrone. The study
also for the first time demonstrated the transformation of the
hitherto unknown compound, 5a-androst-1-en-19-ol-3,17-di-
one (III) into estrone.
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